Wilson Sonsini Goodrich & Rosati advised MBX Biosciences on patent matters on the transaction.MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, announced a $63.5 million Series C…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
